SCM
LENZ

Sterling Capital Management’s LENZ Therapeutics LENZ Stock Holding History

Sterling Capital Management’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19K Buy
130
+21
+19% +$295 ﹤0.01% 3072
2025
Q4 		$1.74K Buy
109
+70
+179% +$2.04K ﹤0.01% 3081
2025
Q3 		$1.82K Sell
39
-4
-9% -$147 ﹤0.01% 2993
2025
Q2 		$1.26K Sell
43
-174
-80% -$4.73K ﹤0.01% 3025
2025
Q1 		$5.58K Sell
217
-185
-46% -$4.56K ﹤0.01% 2109
2024
Q4 		$11.6K Buy
402
+362
+905% +$11K ﹤0.01% 2098
2024
Q3 		$950 Buy
+40
New +$888 ﹤0.01% 2558

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $46.5B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return